Send feedback

GBA2 p.Trp166Arg

c.496T>C · rs980564749 · VCV2150017

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.9756 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00267%, afr)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Spastic paraplegia

Computational evidence

Protein change
AlphaMissense0.9756likely pathogenic · top 6% in GBA2
REVEL0.29benign-leaning
SaProtLLR -6.87tolerated
⇒ AlphaMissense calls this damaging; REVEL and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.4GERP 0.7, phastCons 1
Regional constrainto/e 0.88unconstrained · MANE · 12 kb · p 2e-05 · regional, not allelic
Overall
CADD26.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00267% African / African-American · 2/74,896 alleles
Filtering AF 0.000764% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000606%
Overall 0.00112% 18/1,613,254 alleles · very rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00267% 37,448
Remaining individualsnot grpmax-eligible 0.0016% 62,464
European (non-Finnish) 0.00127% 78,621

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GBA2
Protein
p.Trp166Arg
Coding
c.496T>C
MANE Select
NM_020944
dbSNP
rs980564749
Type
single nucleotide variant
Location
chr9:35744368 (GRCh38)
Gene constraint
LOEUF 0.773 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 89.77
Residue 166
a UniProt-annotated variant site (in spg46; loss of glucosylceramide catabolic process)
Full GBA2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gba2-p-trp166arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown